{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:34:18Z","timestamp":1790814858886,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020829","name":"Japanese Gastric Cancer Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00464-025-11595-7","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T13:12:47Z","timestamp":1739452367000},"page":"2304-2315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of laparoscopic and open gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: a propensity score matching analysis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-9377","authenticated-orcid":false,"given":"Keijiro","family":"Sugimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Motoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishi","family":"Kentaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Hamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Masuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Fujitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"3","key":"11595_CR1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"11595_CR2","first-page":"146","volume":"4","author":"S Kitano","year":"1994","unstructured":"Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 4(2):146\u2013148","journal-title":"Surg Laparosc Endosc"},{"issue":"12","key":"11595_CR3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2015.63.7215","volume":"34","author":"Y Hu","year":"2016","unstructured":"Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J et al (2016) Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol 34(12):1350\u20131357","journal-title":"J Clin Oncol"},{"issue":"20","key":"11595_CR4","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/jama.2019.5359","volume":"321","author":"J Yu","year":"2019","unstructured":"Yu J, Huang C, Sun Y, Su X, Cao H, Hu J et al (2019) Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial. JAMA 321(20):1983\u20131992","journal-title":"JAMA"},{"issue":"1","key":"11595_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamasurg.2021.5104","volume":"157","author":"C Huang","year":"2022","unstructured":"Huang C, Liu H, Hu Y, Sun Y, Su X, Cao H et al (2022) Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: five-year outcomes from the CLASS-01 randomized clinical trial. JAMA Surg 157(1):9\u201317","journal-title":"JAMA Surg"},{"issue":"6","key":"11595_CR6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/SLA.0000000000003217","volume":"270","author":"HJ Lee","year":"2019","unstructured":"Lee HJ, Hyung WJ, Yang HK, Han SU, Park YK, An JY et al (2019) Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT). Ann Surg 270(6):983\u2013991","journal-title":"Ann Surg"},{"issue":"28","key":"11595_CR7","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1200\/JCO.20.01210","volume":"38","author":"WJ Hyung","year":"2020","unstructured":"Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W et al (2020) Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: the KLASS-02-RCT randomized clinical trial. J Clin Oncol 38(28):3304\u20133313","journal-title":"J Clin Oncol"},{"issue":"10","key":"11595_CR8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamasurg.2022.2749","volume":"157","author":"SY Son","year":"2022","unstructured":"Son SY, Hur H, Hyung WJ, Park YK, Lee HJ, An JY et al (2022) Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: 5-year outcomes of the KLASS-02 randomized clinical trial. JAMA Surg 157(10):879\u2013886","journal-title":"JAMA Surg"},{"issue":"11","key":"11595_CR9","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1007\/s00268-015-3160-z","volume":"39","author":"N Inaki","year":"2015","unstructured":"Inaki N, Etoh T, Ohyama T, Uchiyama K, Katada N, Koeda K et al (2015) A multi-institutional, prospective, phase II feasibility study of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer (JLSSG0901). World J Surg 39(11):2734\u20132741","journal-title":"World J Surg"},{"issue":"5","key":"11595_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamasurg.2023.0096","volume":"158","author":"T Etoh","year":"2023","unstructured":"Etoh T, Ohyama T, Sakuramoto S, Tsuji T, Lee SW, Yoshida K et al (2023) Five-year survival outcomes of laparoscopy-assisted vs open distal gastrectomy for advanced gastric cancer: the JLSSG0901 randomized clinical trial. JAMA Surg 158(5):445\u2013454","journal-title":"JAMA Surg"},{"issue":"1","key":"11595_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11\u201320","journal-title":"N Engl J Med"},{"issue":"12","key":"11595_CR12","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"SE Al-Batran","year":"2016","unstructured":"Al-Batran SE, Hofheinz RD, Pauligk C, Kopp HG, Haag GM, Luley KB et al (2016) Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2\/3 trial. Lancet Oncol 17(12):1697\u20131708","journal-title":"Lancet Oncol"},{"issue":"10184","key":"11595_CR13","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet 393(10184):1948\u20131957","journal-title":"Lancet"},{"issue":"8","key":"11595_CR14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1470-2045(21)00297-7","volume":"22","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z et al (2021) Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial. Lancet Oncol 22(8):1081\u20131092","journal-title":"Lancet Oncol"},{"issue":"11","key":"11595_CR15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00595-024-02853-7","volume":"54","author":"M Motoori","year":"2024","unstructured":"Motoori M, Kishi K, Yamamoto K, Takeno A, Hara H, Murakami K et al (2024) Prognostic factors and significance of postoperative adjuvant chemotherapy in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy followed by gastrectomy. Surg Today 54(11):1379\u20131387","journal-title":"Surg Today"},{"issue":"8","key":"11595_CR16","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1007\/s00464-023-10052-7","volume":"37","author":"H Zhong","year":"2023","unstructured":"Zhong H, Liu X, Tian Y, Cao S, Li Z, Liu G et al (2023) Comparison of short- and long-term outcomes between laparoscopic and open gastrectomy for locally advanced gastric cancer following neoadjuvant chemotherapy: a propensity score matching analysis. Surg Endosc 37(8):5902\u20135915","journal-title":"Surg Endosc"},{"issue":"10","key":"11595_CR17","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1007\/s00464-015-4739-z","volume":"30","author":"Z Li","year":"2016","unstructured":"Li Z, Shan F, Wang Y, Li S, Jia Y, Zhang L et al (2016) Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results. Surg Endosc 30(10):4265\u20134271","journal-title":"Surg Endosc"},{"issue":"4","key":"11595_CR18","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00464-020-07552-1","volume":"35","author":"M Fujisaki","year":"2021","unstructured":"Fujisaki M, Mitsumori N, Shinohara T, Takahashi N, Aoki H, Nyumura Y et al (2021) Short- and long-term outcomes of laparoscopic versus open gastrectomy for locally advanced gastric cancer following neoadjuvant chemotherapy. Surg Endosc 35(4):1682\u20131690","journal-title":"Surg Endosc"},{"issue":"12","key":"11595_CR19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamasurg.2019.3473","volume":"154","author":"Z Li","year":"2019","unstructured":"Li Z, Shan F, Ying X, Zhang Y et al (2019) Assessment of laparoscopic distal gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: a randomized clinical trial. JAMA Surg 154(12):1093\u20131101","journal-title":"JAMA Surg"},{"issue":"1","key":"11595_CR20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s10120-020-01109-w","volume":"24","author":"N van der Wielen","year":"2021","unstructured":"van der Wielen N, Straatman J, Daams F, Rosati R, Parise P, Weitz J et al (2021) Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. Gastric Cancer 24(1):258\u2013271","journal-title":"Gastric Cancer"},{"issue":"9","key":"11595_CR21","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1007\/s00464-023-10278-5","volume":"37","author":"N van der Wielen","year":"2023","unstructured":"van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C et al (2023) Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial. Surg Endosc 37(9):7317\u20137324","journal-title":"Surg Endosc"},{"key":"11595_CR22","volume-title":"TMN classification of Malignant tumors","author":"JDGM Brierley","year":"2017","unstructured":"Brierley JDGM, Wittekind C (2017) TMN classification of Malignant tumors, 8th edn. Wiley-Blackwell, Oxford","edition":"8"},{"issue":"2","key":"11595_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Japanese Gastric Cancer A","year":"2011","unstructured":"Japanese Gastric Cancer A (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14(2):101\u2013112","journal-title":"Gastric Cancer"},{"issue":"1","key":"11595_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","volume":"26","author":"Japanese Gastric Cancer A","year":"2023","unstructured":"Japanese Gastric Cancer A (2023) Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer 26(1):1\u201325","journal-title":"Gastric Cancer"},{"issue":"2","key":"11595_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205\u2013213","journal-title":"Ann Surg"},{"issue":"4","key":"11595_CR26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejso.2017.01.008","volume":"43","author":"A Kaito","year":"2017","unstructured":"Kaito A, Kinoshita T, Shitara K, Shibasaki H, Nishida T (2017) Timing of initiation of adjuvant chemotherapy for gastric cancer: a case-matched comparison study of laparoscopic vs. open surgery. Eur J Surg Oncol 43(4):801\u2013807","journal-title":"Eur J Surg Oncol"},{"issue":"18","key":"11595_CR27","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357(18):1810\u20131820","journal-title":"N Engl J Med"},{"issue":"1","key":"11595_CR28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1245\/s10434-014-3949-2","volume":"22","author":"HS Park","year":"2015","unstructured":"Park HS, Jung M, Kim HS, Kim HI, An JY, Cheomg JH et al (2015) Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer. Ann Surg Oncol 22(1):224\u2013231","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"11595_CR29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10120-017-0767-9","volume":"21","author":"K Fujitani","year":"2018","unstructured":"Fujitani K, Kurokawa Y, Takeno A, Endoh S, Ohmori T, Fujita J et al (2018) Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer? Gastric Cancer 21(3):446\u2013452","journal-title":"Gastric Cancer"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-11595-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-11595-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-11595-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T23:25:12Z","timestamp":1743031512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-11595-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["11595"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-11595-7","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Keijiro Sugimura, Masaaki Motoori, Kishi Kentaro, Kazuyoshi Yamamoto, Atsushi Takeno, Hisashi Hara, Takuya Hamakawa, Kohei Murakami, Yujiro Nakahara, Toru Masuzawa, Takeshi Omori, Yukinori Kurokawa, Kazumasa Fujitani, and Yuichiro Doki declare no conflicts of interest or financial ties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}